-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:
We lower our 12-month target by $12 to $123, on an EV/EBITDA of 12.0x our 2026 EBITDA estimate, a discount to the U.S. peer average of 13.6x but a premium to the international peer average of 8.4x. We lower our 2026 EPS view by $0.12 to $5.93 and 2027 by $0.19 to $6.58. CRH executed aggressive capital allocation with $1.9B of divestitures and $0.9B in acquisitions, including the pending $0.7B Axius Water deal. We have a positive view of CRH's continued expansion into the attractive water infrastructure end market. Conflict in Iran poses significant headwinds, as elevated fuel costs over a sustained period could lead to construction budget constraints and prohibitive financing costs at higher for longer interest rates. Labor challenges remain a concern, in terms of both availability and cost. We see only slight adjusted EBITDA margin expansion in 2026, up 20 bps to 20.7%. Valuation limits upside potential, with shares trading ~15% above its two-year historical forward average EV/EBITDA.